Powered by breakthrough technology, our vision of a mouth-watering, affordable and healthy protein is fast approaching - we’ve pioneered a strategy to scale cultivated meat that eliminates the industry’s largest cost driver with zero genetic engineering.

Previously known as Higher Steaks Ltd, we’ve successfully scaled from a compact start-up to a dynamic company of 50+ creative scientists, engineers and operators, committed to a massive takeover of the food industry. We’ve developed a scalable production process that can cut costs, drastically reduce waste materials and improve the health of consumers.

We’ve raised capital totalling $37M from Balderton, Lowercarbon Capital, RedAlpine, Sam Altman (Open AI founder) and Max Altman as well as the UK government through a $1.2M Innovate UK grant. 

From the cell to the sizzle, our Uncommon Bacon and Uncommon Belly are packed full of nutritious goodness and fantastic flavour; paving the way for an Uncommonly good future of delicious, healthy and sustainable meat.

Unleash your creativity and join us!


The Pearse Lyons Accelerator

Dismatrix Group / Planthesis Fund

Balderton Capital

Redalpine

East Alpha

Lowercarbon Capital

Danielle Walsh

Max Altman

Miray Zaki

Sam Altman

Sebastiano Cossia Castiglioni

Uncommon

Recursion Pharmaceuticals is a biotech company focused on drug discovery and development using advanced computational methods.

Recursion Pharmaceuticals

Pepper Bio is a drug discovery company that provides actionable insights using computational methods.

Pepper Bio

Aitia is a company involved in advanced computational drug discovery methods.

Aitia

Terray Therapeutics is a biotech company focused on leveraging computational methods for drug discovery and development.

Terray Therapeutics

Ardigen is a company focusing on drug discovery and development using advanced computational methods.

Ardigen

Insitro is a company specializing in drug discovery and development through advanced computational techniques.

Insitro

Rebiotix is a company involved in drug discovery and development with a focus on computational methods.

Rebiotix

Gritstone Bio is a biotech company focused on drug discovery and development using advanced computational methods.

Gritstone Bio

Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines for drug discovery.

Arkuda Therapeutics

Uncommon Bio is a biotechnology company focused on the development of advanced computational methods and technologies to understand and engineer complex biological systems. Their work aims to revolutionize drug discovery and development by leveraging machine learning and other cutting-edge computational techniques.

Uncommon Bio

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

logo

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general	May 7, 2024 12:36 PM	3aff262f
public peers	general	May 7, 2024 12:36 PM	77265488
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 7, 2024 12:36 PM	57996b76
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
peers	general
news basic	general	May 7, 2024 12:36 PM	90135e97
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
logo	meta
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

CO:UNCOMMONBIO

Uncommon Bio